ASH Conference Coverage
Featured Articles
(AJMC Managed Markets Network) Dec 7, 2019 - Successors to the first generation of chimeric antigen receptor (CAR) T-cell treatments will attack multiple targets and address the complexity of the manufacturing process by bringing uniformity to the creation of therapies, presenters said at the 61st American Society of Hematology Annual...
Read Article
(Regeneron) Dec 8, 2019 - Regeneron Pharmaceuticals, Inc. today announced initial clinical data for REGN5458, a BCMAxCD3 bispecific antibody, in patients with relapsed or refractory (R/R) multiple myeloma. BCMA (B-cell maturation antigen) is a protein that is typically over-expressed on multiple myeloma cells. REGN5458 is designed to...
Read Article
Latest Articles
December 08, 2019
December 08, 2019
December 08, 2019
December 08, 2019
December 08, 2019
December 08, 2019
December 08, 2019
December 08, 2019
View More
News Commentary
There is no ASH Conference Coverage commentary.

OBR Blog
There are no ASH Conference Coverage blog entries.